Holen Sie sich die Stockscreener-App
10.50
3.75%
0.38
Handel nachbörslich:
10.50
Immucell Corp Aktie (ICCC) Neueste Nachrichten
ImmuCell Shares Rose Ahead of Holiday; Tuesday’s Open in Focus - Bez Kabli
ImmuCell Q1 Earnings Rise Y/Y as Sales Climb on Strong Demand - Yahoo Finance
ICCC SEC FilingsImmucell 10-K, 10-Q, 8-K Forms - Stock Titan
ICCC Technical Analysis | Trend, Signals & Chart Patterns | IMMUCELL CORP (NASDAQ:ICCC) - ChartMill
ImmuCell Corporation (NASDAQ:ICCC) Q1 2026 Earnings Call Transcript - Insider Monkey
ImmuCell Q1 Earnings Call Highlights - sharewise.com
Earnings call transcript: ImmuCell Q1 2026 marks milestone with revenue surge - Investing.com
ImmuCell (NASDAQ: ICCC) posts strong Q1 2026 growth, higher margins and cash - Stock Titan
ImmuCell (NASDAQ: ICCC) grows Q1 2026 revenue 28% and boosts earnings - Stock Titan
Calf-health maker ImmuCell secures $2M to expand First Defense output - Stock Titan
ImmuCell Corporation 2025 10-K/A Annual Report Filing Details, Address, and SEC Cover Information - Minichart
ImmuCell (NASDAQ: ICCC) files 10-K amendment to update exhibit list - Stock Titan
Here’s Why ImmuCell Corporation (ICCC) is Emerging as an Intriguing Micro-Cap Opportunity - Yahoo Finance
TradingKey - TradingKey
ImmuCell | 4: Statement of changes in beneficial ownership of securities-Director Basse Gloria F - Moomoo
ImmuCell Corporation Files Form 8-K with SEC: Company Details, NASDAQ Listing, and Key Entity Information - Minichart
[8-K] IMMUCELL CORP /DE/ Reports Material Event - Stock Titan
ImmuCell keeps Q1 sales outlook unchanged ahead of May 15 results call - Stock Titan
Short Interest in ImmuCell Corporation (NASDAQ:ICCC) Decreases By 20.8% - MarketBeat
ImmuCell (NASDAQ:ICCC) Stock Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
The Christmas party is still ongoing in these stocks: Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals, ImmuCell - MSN
ImmuCell (NASDAQ: ICCC) outlines 2026 strategy, equity plan and pay - Stock Titan
ImmuCell (ICCC) director discloses 17,899 stock options grant details - Stock Titan
ImmuCell (NASDAQ: ICCC) director lists 17,899 stock options - Stock Titan
ImmuCell : Corporate Presentation (Investor Relations April 2026 Final) - marketscreener.com
The Zacks Analyst Blog The Goldman Sachs, NextEra, Shopify, Landmark and ImmuCell - Zacks Investment Research
ICCC (ImmuCell Corporation) rises 1.78 percent after posting a 0.31 dollar per share loss for Q4 2025.Elite Trading Signals - newser.com
ICCC ImmuCell Corporation shares gain nearly two percent following release of its Q4 2025 earnings report.Revenue Growth - newser.com
[Form 4] IMMUCELL CORP /DE/ Insider Trading Activity - Stock Titan
ImmuCell (ICCC) grants director 11,933 stock options at $7.60 - Stock Titan
Director Gloria Basse granted 11,933 ImmuCell (ICCC) stock options - Stock Titan
ImmuCell (ICCC) director Paul Wainman receives 11,933 stock options at $7.60 - Stock Titan
650K-share equity plan and officer exculpation up for vote — ImmuCell (NASDAQ: ICCC) - Stock Titan
ImmuCell (ICCC) VP Brockmann granted 5,000 incentive stock options - Stock Titan
ImmuCell (ICCC) director receives grant of 10,000 stock options - Stock Titan
ImmuCell (ICCC) director awarded 10,000 stock options at $5.49 strike - Stock Titan
ImmuCell (ICCC) director awarded 10,000 options at $5.49 exercise price - Stock Titan
ImmuCell (ICCC) director Steven Rosgen granted 10,000 stock options at $5.49 - Stock Titan
ImmuCell (ICCC) director receives 10,000 non-qualified stock options at $5.49 - Stock Titan
ImmuCell (ICCC) adds industry veterans to a smaller, more independent board - Stock Titan
ImmuCell appoints two directors, expands to 7-member board - Investing.com
ImmuCell appoints two directors, expands to 7-member board By Investing.com - Investing.com South Africa
Two animal health veterans join ImmuCell as board shrinks to 7 - Stock Titan
Is ImmuCell Corporation (ICCC) Stock undervalued by the market | Price at $7.26, Up 13.79%Wall Street Picks - Newser
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):